TRIAD - Treatment of Insomnia and Depression
Trial ID or NCT#
The aim of the proposed three-site study is to increase the rate of full remission from major depressive disorder (MDD) at the end of 16 weeks of treatment for people who experience both major depressive disorder and insomnia.
Contact us to find out if this trial is right for you.
About this Clinical Trial
Your Message Will Go ToHaddas Elisha
Go Back To The Trial